Work

Strategic framework to advance scientific innovation in clinically dominant diseases in traditional Chinese medicine: Plasma cell mastitis

Year: 2025
Type: article
Abstract: In accordance with the Guiding Opinions of the Central Committee of the Communist Party of China and the State Council on Promoting the Inheritance and Innovation of Traditional Chinese Medicine (TCM), the China Association of Chinese Medicine (CACM) organized multidisciplinary symposia on TCM-dominant diseases with the aim of advancing research on clinically dominant diseases in TCM, supporting specialty development, cultivating clinical talent, developing strategic plans for national science, and fostering academic innovation. The 42nd Academic Salon on Clinically Dominant Diseases, which was convened in Shanghai on 24 November 2024, brought together TCM experts, Western medicine experts, and interdisciplinary researchers for in-depth discussions on the current status, strengths, and limitations of and strategies to improve the integrated diagnosis and treatment of plasma cell mastitis (PCM). While consensus had been reached on recommendations for TCM and integrated approaches, detailed research pathways remain to be developed. In this work, we systematically examine the pathogenesis of and clinical management challenges related to PCM. Building on the therapeutic strengths of TCM, we propose five prioritized research domains with corresponding scientific planning: (1) Early identification and intervention strategies for PCM; (2) The optimization of TCM syndrome differentiation systems for PCM; (3) The standardization of efficient evaluation metrics for PCM therapies; (4) Mechanistic studies on the pathogenesis of PCM and TCM therapeutic targets; (5) Prevention protocols and complication management frameworks for PCM. We further delineate recommended research directions, anticipated outcomes, value propositions, and funding priorities. The aim of this research model, which was derived from the PCM-focused academic salon series, is to advance the development of high-quality TCM practices by informing national scientific planning, innovative drug development, research priorities, and the formulation of clinical guidelines.
Authors: Siyuan TU, Yulian YIN, Jiachen XU, Hongfeng CHEN, Xueqing WU, Yiting JIN, Wei ZHU, Na FU, Jiayu SHENG, Xiaofei LIU, Chengyu CHU, Meina YE
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W4414616005
FWCI: 0.806
Cites: 38
Cited by: 1
Related to: 10